Follow Us:Follow Us on Twitter Like Us on Facebook Follow Us on Google+ Watch videos on our Youtube channel
Robert Figlin, MD, FACP
Professor of Medicine and Biomedical Sciences
Steven Spielberg Family Chair in Hematology Oncology
Director, Division of Hematology Oncology
Deputy Director, Samuel Oschin Comprehensive Cancer Institute
Robert Figlin, MD, FACP, is Professor of Medicine and Biomedical Sciences, Director of the Division of Hematology Oncology and Deputy Director at Cedars-Sinai’s Samuel Oschin Comprehensive Cancer Institute. He holds the Steven Spielberg Family Chair in Hematology Oncology. Dr. Figlin is board-certified in both medical oncology and internal medicine.
Dr. Figlin previously served as Professor and Chair of the Department of Medical Oncology and Therapeutic Research at City of Hope. He also was affiliated with the Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA) for more than 20 years, where he held a number of leadership positions in the areas of urologic cancer, hematology/oncology and thoracic oncology.
Dr. Figlin is a prolific researcher known for advancing urologic and lung cancer therapies. His expertise has resulted in the development of novel anti-cancer drugs that have led to improved outcomes for patients. Dr. Figlin has written more than 300 peer-reviewed publications, authored several books on kidney cancer and published more than 60 book chapters on new approaches to cancer treatment.
He is a fellow of the American College of Physicians and the International Society for Biologic Therapy as well as a member of the American Society of Clinical Oncology, the American Association for Cancer Research, the National Comprehensive Cancer Center Network and the American Urological Association.
Dr. Figlin earned his bachelor’s degree in chemistry from Temple University where he also earned a graduate degree in organic chemistry. He earned his medical degree from the Medical College of Pennsylvania. Dr. Figlin served his internship and residency at Cedars-Sinai Medical Center where he was Chief Medical Resident and completed a fellowship in hematology/oncology at UCLA.